Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pleural Effusion, Malignant 4Pleural Effusion 2Wound Infection 1Urinary Tract Infections 1Stomatitis 1Skin Neoplasms 1Sepsis 1Prostatic Neoplasms 1Pneumothorax 1Fever 1Esophageal Neoplasms 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Povidone-Iodine × Clear all
NCT02479347 2021-09-09

Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 4 Completed
2,158 enrolled
Breast

Breast Neoplasms, Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡